Responses
Clinical and epidemiological research
Extended report
Lesinurad in combination with allopurinol: a randomised, double-blind, placebo-controlled study in patients with gout with inadequate response to standard of care (the multinational CLEAR 2 study)
Compose a Response to This Article
Other responses
No responses have been published for this article.